Blueshift Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Blueshift Asset Management's LLY Position: Q2 2026 in Review
Blueshift Asset Management reduced its Eli Lilly (LLY) stake by 62% in Q2 2026, selling an estimated $812K and leaving 479 shares worth $575K. The position accounts for 0.13% of the portfolio, ranked #162.
Blueshift Asset Management first reported a position in LLY in Q4 2018 and has held it in 15 quarters since. The position peaked at $3.14M in Q1 2021. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Blueshift Asset Management held 479 shares of Eli Lilly worth $575K as of Q2 2026.
- Blueshift Asset Management sold 795 Eli Lilly shares in Q2 2026, an estimated $812K.
- Eli Lilly made up 0.13% of Blueshift Asset Management's portfolio in Q2 2026, its #162 holding.
- Blueshift Asset Management first reported a position in Eli Lilly in Q4 2018 and has held it in 15 quarters since.
- Blueshift Asset Management's Eli Lilly position peaked at $3.14M in Q1 2021.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.